HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV, Surveillance Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Department of Epidemiology, New York University School of Global Public Health, New York, NY, USA.
Harm Reduct J. 2024 Oct 18;21(1):187. doi: 10.1186/s12954-024-01107-6.
People who inject drugs (PWID) are a key population at risk of HIV in Iran. We measured the prevalence and covariates of HIV-related risk behaviours among PWID in Iran.
We conducted a respondent-driven bio-behavioural surveillance survey among PWID from July 2019 to March 2020 in 11 major cities. We assessed PWID's recent (i.e., last three months) HIV-related risk behaviours using a four-level categorical variable: Only unsafe injection (i.e., sharing needles/syringes or injecting equipment), only unsafe sex (i.e., unprotected sex), dual HIV risk (i.e., both unsafe injection and unprotected sex), and safe injection and sex. Data were summarized using RDS-weighted analysis. Multinomial logistic regression models were built to characterize HIV-related risk behaviours and relative risk ratio (RRR) with 95% confidence interval (CI) were reported.
Overall, 2562 men who inject drugs (MWID) were included in the regression analysis. The RDS-weighted prevalence of dual HIV risk was 1.3% (95% CI: 0.8, 1.9), only unsafe injection was 4.5%, and only unsafe sex was 11.8%. Compared to the safe injection and sex group, dual HIV risk was significantly and positively associated with multiple partnership (RRR = 15.06; 3.30, 68.73). Only unsafe injection was significantly associated with homelessness in the last 12 months (RRR: 3.02; 95% CI: 1.34, 6.80). Only unsafe sex was significantly associated with multiple partnership (RRR = 6.66; 4.27, 10.38), receiving free condoms (RRR = 1.71; 1.01, 2.89), receiving free needles (RRR = 2.18; 1.22, 3.90), and self-received risk for HIV (RRR = 2.51; 1.36, 4.66). Moreover, history of HIV-testing in the last three months was significantly associated with only unsafe injection (RRR = 2.71; 1.84, 3.80). Among the 90 women who injected drugs, none reported dual HIV risk behaviours.
While the low prevalence of dual HIV risk among PWID is encouraging, unprotected sexual practices among PWID is concerning. Expanding sexual health education and care services as well as tailored interventions aimed at reducing high-risk sexual activities among PWID are warranted. Additionally, tackling potential misperceptions about risk of HIV transmission among PWID in Iran is warranted.
在伊朗,注射毒品的人(PWID)是感染艾滋病毒的一个关键人群。我们衡量了伊朗 PWID 与艾滋病毒相关的风险行为的流行程度和协变量。
我们于 2019 年 7 月至 2020 年 3 月期间在 11 个主要城市对 PWID 进行了基于应答者驱动的生物行为监测调查。我们使用四级分类变量评估了 PWID 在最近三个月(即过去三个月)内与 HIV 相关的风险行为:仅不安全注射(即共用针头/注射器或注射设备)、仅不安全性行为(即无保护性行为)、双重 HIV 风险(即两者兼有不安全注射和无保护性行为)和安全注射和性行为。使用 RDS 加权分析对数据进行总结。建立了多变量逻辑回归模型,以描述与 HIV 相关的风险行为,并报告了 95%置信区间(CI)的相对风险比(RRR)。
总体而言,共有 2562 名男性注射毒品者(MWID)纳入回归分析。双重 HIV 风险的 RDS 加权患病率为 1.3%(95%CI:0.8,1.9),仅不安全注射为 4.5%,仅不安全性行为为 11.8%。与安全注射和性行为组相比,双重 HIV 风险与多伙伴关系显著且呈正相关(RRR=15.06;3.30,68.73)。仅不安全注射与过去 12 个月的无家可归显著相关(RRR:3.02;95%CI:1.34,6.80)。仅不安全性行为与多伙伴关系显著相关(RRR=6.66;4.27,10.38),接受免费避孕套(RRR=1.71;1.01,2.89),接受免费针头(RRR=2.18;1.22,3.90),以及自我报告的 HIV 风险(RRR=2.51;1.36,4.66)。此外,过去三个月内进行 HIV 检测的历史与仅不安全注射显著相关(RRR=2.71;1.84,3.80)。在 90 名注射女性中,没有报告双重 HIV 风险行为。
尽管 PWID 中双重 HIV 风险的低流行率令人鼓舞,但 PWID 中无保护的性行为令人担忧。扩大性健康教育和护理服务,以及针对 PWID 减少高风险性行为的量身定制的干预措施,都是必要的。此外,有必要解决伊朗 PWID 对 HIV 传播风险的潜在误解。